Literature DB >> 15482327

Nimesulide and indomethacin induce apoptosis in head and neck cancer cells.

Martina Pelzmann1, Dietmar Thurnher, Claudia Gedlicka, Helga Martinek, Birgit Knerer.   

Abstract

BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) are known to inhibit the enzyme cyclooxygenase (COX). There are two isoforms of the enzyme. Recent investigations indicate that both isoforms, COX-1 and COX-2, are involved in carcinogenesis.
METHODS: We investigated the effects of nimesulide, a COX-2 selective and indomethacin, a non-selective NSAID on the head and neck squamous cell carcinoma (HNSCC) cell lines SCC-9 and SCC-25. Effects on cell numbers and apoptosis were assayed by cell counting, immunofluorescence and fluorescence activated cell sorting (FACS). COX expression was examined by Western blotting.
RESULTS: The investigated cell lines express COX-1 and COX-2. Nimesulide and indomethacin induce apoptosis and cause a reduction of cell number. Incubation with NSAIDs upregulated COX-2 expression.
CONCLUSION: The results of our study on HNSCC cells together with data from different studies showing anti-cancer activity of NSAIDs suggest that COX inhibitors could play a role in HNSCC treatment and prevention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15482327     DOI: 10.1111/j.1600-0714.2004.00216.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  4 in total

1.  The cyclooxygenase-2 inhibitor nimesulide, a nonsteroidal analgesic, decreases the effect of radiation therapy in head-and-neck cancer cells.

Authors:  Cornelia Czembirek; Christina Eder-Czembirek; Boban M Erovic; Dritan Turhani; Andreas Spittler; Edgar Selzer; Richard Pötter; Dietmar Thurnher
Journal:  Strahlenther Onkol       Date:  2009-05-15       Impact factor: 3.621

2.  Indomethacin Treatment Post-irradiation Improves Mouse Parotid Salivary Gland Function via Modulation of Prostaglandin E2 Signaling.

Authors:  Kristy E Gilman; Jean M Camden; Lucas T Woods; Gary A Weisman; Kirsten H Limesand
Journal:  Front Bioeng Biotechnol       Date:  2021-07-21

3.  Outpatient Follow-up and Secondary Prevention for Melanoma Patients.

Authors:  Ryan G Gamble; Daniel Jensen; Andrea L Suarez; Anne H Hanson; Lauren McLaughlin; Jodi Duke; Robert P Dellavalle
Journal:  Cancers (Basel)       Date:  2010-06-07       Impact factor: 6.639

4.  Dihydropyrazole Derivatives Containing Benzo Oxygen Heterocycle and Sulfonamide Moieties Selectively and Potently Inhibit COX-2: Design, Synthesis, and Anti-Colon Cancer Activity Evaluation.

Authors:  Xiao-Qiang Yan; Zhong-Chang Wang; Bo Zhang; Peng-Fei Qi; Gui-Gen Li; Hai-Liang Zhu
Journal:  Molecules       Date:  2019-04-30       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.